Detection of activin A and follistatin as potential biomarkers in women with ovarian endometriosis
article
OA: closed
public-domain-us
AI-generated summary
This study found significantly elevated levels of activin A and follistatin in women with ovarian endometriosis compared to healthy controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a condition characterized by the growth of tissue similar to the uterine lining outside the uterus. This study aimed to evaluate certain sex hormones and determine the levels of activin A and follistatin in women with endometriosis. The study included 45 women with ovarian endometriosis and 45 healthy women as a control group. Hormone levels were measured using a VIDAS analyzer (bioMérieux, France), while activin A and follistatin levels were estimated using ELISA (BT LAB). The baseline characteristics (age, weight, BMI, WHR, WHtR, education, and residency) of the patients were comparable to those in controls (P > 0.05). Similarly, there was no difference in LH and prolactin levels (P > 0.05). Patients with endometriosis had significantly higher FSH (7.17 ± 1.76 vs. 5.99 ± 2.22, P = 0.010) and estradiol levels (136.67 ± 27.27 vs. 57.84 ± 15.16, P < 0.001), while progesterone (0.35 ± 0.11 vs. 0.44 ± 0.16, P = 0.045), testosterone [0.69 (0.45-0.82) vs. 0.81 (0.73-0.88), P = 0.001], and AMH [0.24 (0.15-0.36) vs. 4.08 (2.42-7.34), P = 0.001] were significantly lower. Activin A [11.24 (11.02-11.81) vs. 1.26 (1.02-2.11), P < 0.001] and follistatin [23.36 (19.53-46.86) vs. 12.40 (8.81-18.93), P < 0.001] were markedly elevated in patients compared to controls. The results for Activin A and Follistatin also showed a significant increase, indicating their potential use as promising biomarkers in the diagnosis of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes via openalex
- High serum follistatin levels in women with ovarian endometriosis via openalex
- Impact of endometriosis on the ovarian follicles via openalex
- Peritoneal Endometriosis Impairs Ovarian Reserve and Increases Atresia in a Rat Model via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Serum Markers for the Noninvasive Diagnosis of Endometriosis via openalex
- The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study via openalex
- W4401429470 via openalex
- W4402369061 via openalex
- W4403007827 via openalex
- W4403480737 via openalex
- W4404204872 via openalex
- W4404378485 via openalex
- W4404515493 via openalex
- W4408186283 via openalex
- W1543707496 via openalex
- W4413105490 via openalex
- W1991404560 via openalex
- W2002530713 via openalex
- W2033021374 via openalex
- W3194419458 via openalex
- W4212842994 via openalex
- W4234160457 via openalex
- W4379469062 via openalex
- W4380792625 via openalex
- W4387454801 via openalex
Source provenance
- europepmc
- last seen: 2026-08-12T06:07:16.479679+00:00
- openalex
- last seen: 2026-07-24T06:09:49.243201+00:00
- pubmed
- last seen: 2026-08-12T06:02:37.594802+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine